ArticleSouth Asian journal of cancer2025

Safety and Efficacy of Alectinib in the First Line for ALK-Mutated Lung Cancer: A Real-World Data from India.

Ajaykumar Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.